Business Wire India
- The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients
- Breakthrough study conducted by Professor Subhabrata Sen, Shiv Nadar University (India) in collaboration with Professor Ralf Jockers, an expert molecular biologist from Institut Cochin (INSERM, CNRS, Université de Paris, France)
- Animal trials to begin soon as a prelude to human trials
Source: Businesswire